Co-Diagnostics said it released results for the quarter ended September 30, 2026. This filing gives no sales or profit figures, so it does not show whether the business improved or weakened.
The filing points readers to a separate press release, but the text here gives no sales, costs, or profit figures. Without those details, it gives no clear sign that the business improved or weakened.
Follow Co-Diagnostics, Inc. (CODX) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CODX